Preparation method of venenum bufonis extract with low irritation

Through solvent extraction and gel chromatography purification methods, combined with ninhydrin chromatography and screening of maximum ultraviolet absorption wavelength, low-irritating toad extract was prepared, which solved the problem of traditional toad preparations on vascular irritation and significantly reduced its Inflammatory irritation improves the safety of clinical application.

CN118987048AInactive Publication Date: 2024-11-22CHINA NAT INST OF STANDARDIZATION
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411023881.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-29
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

During clinical use, traditional toad pastry preparations will irritate blood vessels, causing redness, swelling and pain, affecting the treatment effect and safety, and limiting their widespread use.

Method used

Using solvent extraction and gel chromatography purification methods, the pyramid extract was extracted by alcohol solvents such as ethanol, combined with methanol dissolution and Sephadex LH-20 gel column elution, and the fractions were screened using ninhydrin chromatogenic reaction and UV maximum absorption wavelength, and specific Fraction was used to prepare low-irritating toad nectar extract.

Benefits of technology

It significantly reduced the inflammatory irritation of toad extract on rat toes, reduced vascular irritation, and improved the safety and clinical application potential of the preparation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004968015140000041
    Figure BDA0004968015140000041
  • Figure BDA0004968015140000051
    Figure BDA0004968015140000051
  • Figure BDA0004968015140000052
    Figure BDA0004968015140000052
Patent Text Reader

Abstract

The venenum bufonis extract with low irritation is prepared through a simple preparation process of solvent extraction and gel chromatography purification in combination with ninhydrin color development and maximum ultraviolet absorption wavelength. Under the condition that the dosage of the venenum bufonis extract is the same as that of venenum bufonis and other venenum bufonis extracts, the venenum bufonis extract prepared by the process disclosed by the invention has the advantage that the inflammatory stimulation on rat toes, such as inflammation (swelling degree), pain (foot lifting times) and the like, is remarkably reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to a method for preparing a low-irritation toad venom extract. Background Art

[0002] Toad venom (Venenum Bufonis) was first recorded in the Treatise on Materia Medica, and its original name was Toad Eyebrow Fat; the name Toad venom first appeared in the Bencao Yanyi, which said: "There is white juice between the eyebrows, which is called Toad venom. Wrap the eyebrows with oil sheets (paper) and crack them, and the venom will come out of the sheet (paper) and be used as medicine." The 2020 edition of the Pharmacopoeia of the People's Republic of China stipulates that Toad venom (Venenum Bufonis) is the dried secretion of the Chinese giant toad Bufo bufogargarizans Cantor or the black-rimmed toad Bufo melanostictus Schneider, both of the Toad family.

[0003] According to traditional Chinese medicine theory, toad venom has the effects of clearing away heat and detoxifying, reducing swelling and relieving pain, and awakening the mind. Traditional or modern preparations using toad venom include Liushen Pills, Shexiang Baoxin Pills, Huachansu Injection, Delisheng Injection, etc. According to clinical reports, Huachansu Injection and Delisheng Injection will produce varying degrees of irritation to blood vessels during use, with redness, swelling, and pain as the main characteristics. This not only affects the therapeutic effect of the drug and reduces patient compliance, but also limits its safety and wide application in clinical practice.

[0004] Therefore, how to prepare low-irritation toad venom to alleviate or reduce vascular irritation has important reference and guiding significance for the safe and rational clinical use of toad venom-related preparations. Summary of the invention

[0005] The present invention provides a method for preparing a low-irritation toad venom extract, the preparation method comprising the following steps:

[0006] (1) Solvent extraction: Take toad venom, add alcohol solvent, extract, and filter to obtain the extract;

[0007] (2) Gel chromatography purification: The extract is dissolved in methanol and centrifuged to obtain a supernatant sample; the supernatant sample is loaded onto a gel chromatography column, and after sufficient adsorption, the column is eluted with methanol and the fractions are collected; the fractions with a negative ninhydrin colorimetric reaction and a maximum ultraviolet absorption wavelength of 290 nm to 305 nm are collected to obtain the low-irritation toad venom extract.

[0008] According to an embodiment of the present invention, in step (1), the alcohol solvent is selected from ethanol, methanol, etc.; preferably ethanol.

[0009] According to an embodiment of the present invention, in step (1), during extraction, the concentration of the alcohol solvent is 70%-90%, for example, 75%, 80%, 85%.

[0010] According to an embodiment of the present invention, in step (1), the extraction method is selected from immersion extraction, ultrasonic extraction, reflux extraction, etc.

[0011] According to an embodiment of the present invention, in step (1), the extraction time is 10h-50h, such as 12h, 18h, 24h, 30h, 36h. According to an embodiment of the present invention, in step (1), the number of extractions is 1-5 times, such as 1 time, 2 times, 3 times, etc.

[0012] According to an embodiment of the present invention, in step (1), the toad venom can be first made into a paste with water, and then an alcohol solvent is added for extraction.

[0013] According to an embodiment of the present invention, step (1) is specifically as follows: taking toad venom powder, subdividing toad venom into a paste with water, adding an alcohol solvent, extracting, and filtering to obtain an extract. Optionally, the alcohol solvent in the extract is recovered to remove the alcohol solvent.

[0014] According to an embodiment of the present invention, in step (2), the extract is dissolved in methanol to a methanol concentration of 60%-80%, such as 65%, 70%, or 75%.

[0015] According to an embodiment of the present invention, in step (2), the centrifugation parameter conditions are: rotation speed 6000rpm-10000rpm, time 5min-40min; for example, rotation speed 7000rpm, 8000rpm, 9000rpm, time 10min, 20min, 30min.

[0016] According to an embodiment of the present invention, in step (2), the gel chromatography column is a Sephadex LH-20 gel column.

[0017] According to an embodiment of the present invention, in step (2), the loading step is specifically: aspirating the supernatant sample (for example, using a rubber-tipped dropper), and adding it evenly and slowly along the glass inner wall of the gel chromatography column to fully adsorb it.

[0018] According to an embodiment of the present invention, in step (2), the elution solvent of the gel chromatography column is 60%-80% methanol, such as 65% methanol, 70% methanol, 75% methanol.

[0019] According to an embodiment of the present invention, in step (2), the concentration of the elution solvent of the gel chromatography column is the same as the concentration of the dissolving solvent in the supernatant sample; preferably, the methanol concentrations of the two are the same.

[0020] According to an embodiment of the present invention, in step (2), the ultraviolet maximum absorption wavelength is 295nm-302nm, for example, 295nm, 296nm, 297nm, 298nm, 300nm, 301nm.

[0021] According to an embodiment of the present invention, in step (2), when the gel chromatography column is eluted, one tube is collected every 30 minutes, and a total of 165 tubes are collected.

[0022] According to the embodiment of the present invention, in step (2), the color development reaction of ninhydrin of fractions 1-18 is positive, and the ultraviolet maximum absorption wavelength is 220nm; the color development reaction of ninhydrin of fractions 20-29 is negative, and the ultraviolet maximum absorption wavelength is 296nm; the color development reaction of ninhydrin of fractions 30-41 is negative, and the ultraviolet maximum absorption wavelength is 296nm; the color development reaction of ninhydrin of fractions 42-165 is negative, and the ultraviolet maximum absorption wavelength is 276nm.

[0023] According to an embodiment of the present invention, in step (2), the 20th to 41st fractions are combined to obtain the low-irritation toad venom extract (Fr.2+Fr.3).

[0024] According to an embodiment of the present invention, in step (2), the 20th to 29th fractions are combined to obtain the low-irritation toad venom extract (Fr. 2).

[0025] According to an embodiment of the present invention, in step (2), the 30th to 41st fractions are combined to obtain the low-irritation toad venom extract (Fr. 3).

[0026] According to an embodiment of the present invention, the low-irritation toad venom (Fr.2, Fr.3) extract is rich in steroidal components such as bufotoxin, bufotoxin, bufotoxin, and cinobucoid.

[0027] According to an embodiment of the present invention, the inflammatory stimulation of the toad venom extract prepared by the preparation method is significantly reduced.

[0028] The present invention also provides a low-irritation toad venom extract prepared by the preparation method.

[0029] Beneficial Effects

[0030] The present application uses a simple preparation process of solvent extraction and gel chromatography purification, combined with ninhydrin color development and ultraviolet maximum absorption wavelength, to prepare a low-irritation toad venom extract. At the same dose as toad venom and other toad venom extracts, the toad venom extract prepared by the process of the present application significantly reduces inflammatory stimuli such as inflammation (swelling) and pain (number of times the foot is lifted) on rat toes. BRIEF DESCRIPTION OF THE DRAWINGS

[0031] Figure 1 Representative chromatograms of the fractions.

[0032] Figure 2 These are the chromatograms of Fr.1, Fr.2, Fr.3, and Fr.4. DETAILED DESCRIPTION

[0033] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0034] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.

[0035] Example 1

[0036] 1. Materials

[0037] 1.1 Instrument

[0038] Waters 2695 high performance liquid chromatography workstation (UV detector);

[0039] Hypersil ODS C18 (250 mm × 4.6 mm × 5 μm) column;

[0040] Beckman Coulter ultracentrifuge (Beckman, USA);

[0041] YLS-7B toe volume measuring instrument (Jinan Yiyan Technology Development Co., Ltd.).

[0042] 1.2 Medicines

[0043] Huabuf venom base (China Food and Drug Biological Products Control Institute, batch number 110803-200605), chemical reference substance; resiboflavin base (China Food and Drug Biological Products Control Institute, batch number 110718-201108) is used for content determination, the content is 98.9%; bufalin (Beijing Yingze Naxin Chemical Technology Research Institute, batch number MUST-13091302); bufalin (Beijing Yingze Naxin Chemical Technology Research Institute, batch number 130828); bufalin (Beijing Yingze Naxin Chemical Technology Research Institute, batch number 130809); shabufacine (Beijing Yingze Naxin Chemical Technology Research Institute, batch number 130801).

[0044] 1.3 Reagents

[0045] Ethanol, acetonitrile, formic acid, potassium dihydrogen phosphate, phosphoric acid, ninhydrin, etc. were all of analytical grade, water was ultrapure water (MiLLipore, USA), and the other reagents were of analytical grade.

[0046] 2 Experimental content

[0047] 2.1 Animals

[0048] Twenty clean-grade male SD rats, weighing 180-220 g, with animal certificate number SCXK(Beijing)2012-0001, were provided by Beijing Weitonglihua Experimental Animal Technology Co., Ltd.

[0049] 2.2 Preparation of different molecular weight fractions of toad venom

[0050] Weigh 5g of toad venom powder, add appropriate amount of water to make a paste, add 95% ethanol to make the alcohol concentration reach 80%, soak for 24h, filter, and recover ethanol from the filtrate to obtain the extract. Add methanol to the extract to adjust the final concentration of methanol to 70%, centrifuge (8000rpm×20min), take the supernatant sample and apply it to Sephadex LH-20 gel column. Use a rubber dropper to absorb an appropriate amount of supernatant sample, add it evenly and slowly along the inner wall of the glass for full adsorption. Elute with 70% methanol, collect one tube every 30 minutes, and collect 165 tubes in total.

[0051] Weigh 1g of ninhydrin into a 50mL volumetric flask, dissolve it in ethanol and make up to volume to obtain a 2% ninhydrin solution. The color development method is: use a glass rod to dip a small amount of the solution on the filter paper, and evenly spray 2% ninhydrin test solution for color development.

[0052] For HPLC analysis, mobile phase A was acetonitrile, mobile phase B was 0.5% potassium dihydrogen phosphate (pH adjusted to 3.2 with phosphoric acid), gradient elution, injection volume was 20 μL, column temperature was 30° C., detection wavelength was 296 nm, and gradient elution conditions were as shown in Table 1.

[0053] Table 1 Gradient elution conditions

[0054]

[0055] 2.3 Evaluation of the inflammatory effects of Fr.1, Fr.2, Fr.3, and Fr.4 on rat toes

[0056] Weigh appropriate amounts of toad venom, Fr.1, Fr.2, Fr.3, and Fr.4 to prepare a test sample with a toad venom crude drug concentration of 0.006 g / mL for rat toe irritation experiment. Male SD rats, weighing 200-220 g, 5 rats / group. Before the experiment, fasting but not water, 0.1 mL was subcutaneously injected into the right toe of the rats, and the control group was given an equal volume of 0.9% saline. The toe volume meter was used to measure the swelling of the toes before and after administration, and the number of times the rats lifted their feet within 30 minutes of administration was counted to evaluate the irritation.

[0057] 3 Results

[0058] 3.1 Preparation of different molecular weight fractions Fr.1, Fr.2, Fr.3, and Fr.4 of toad venom

[0059] According to the ninhydrin colorimetric reaction and high performance liquid chromatography analysis: the ninhydrin colorimetric reaction of fractions 1-18 was positive, and the ultraviolet maximum absorption wavelength was 220nm; the ninhydrin colorimetric reaction of fractions 20-29 was negative, and the ultraviolet maximum absorption wavelength was 296nm; the ninhydrin colorimetric reaction of fractions 30-41 was negative, and the ultraviolet maximum absorption wavelength was 296nm; the ninhydrin colorimetric reaction of fractions 42-165 was negative, and the ultraviolet maximum absorption wavelength was 276nm.

[0060] The retention time and maximum absorption wavelength of the mixed reference substance are shown in Table 2, the color development and maximum absorption wavelength of ultraviolet light of ninhydrin are shown in Table 3, and the representative chromatograms of fractions 7, 28, 34, and 70 are shown in Figure 1 According to the above results, No. 1-18, No. 20-29, No. 30-41, No. 42-165 were combined, concentrated, and dried to obtain Fr.1, Fr.2, Fr.3, and Fr.4. The liquid chromatograms of Fr.1, Fr.2, Fr.3, and Fr.4 are shown in Figure 2 Among them, Fr.2 and Fr.3 are rich in steroidal components such as toad venom, toad venom, toad venom, and toad venom.

[0061] Table 2 Retention time and maximum absorption wavelength of mixed reference substances

[0062]

[0063] Table 3 Color development of ninhydrin fractions and maximum UV absorption wavelength

[0064]

[0065] 3.2 Inflammatory effects of Fr.1, Fr.2, Fr.3, and Fr.4 on rat toes

[0066] According to the stimulation swelling score and pain grading: stimulation by the raw drug of toad venom caused moderate swelling (++) and moderate pain (++); Fr.2 and Fr.3 showed moderate swelling (++) and mild pain (+); Fr.1 caused severe swelling (+++) and severe pain (+++), which was the strongest in the toad venom group, and the swelling and pain caused by stimulation were very obvious; Fr.4 caused severe swelling (+++) and mild pain (+). As shown in Table 4-5.

[0067] Table 4 Inflammatory stimulation of rat toes by Fr.1, Fr.2, Fr.3 and Fr.4

[0068]

[0069] Note: * represents P < 0.05 compared with the control group

[0070] Table 5 Scoring of inflammatory irritation of rat toes by Fr.1, Fr.2, Fr.3 and Fr.4

[0071]

[0072] Note: The administration volume of each group was 0.1 mL, and the control group was given an equal volume of 0.9% saline. The swelling score was: severe +++, moderate ++, mild +, none -; the pain score was: severe +++, moderate ++, mild +, none -.

[0073] From the above results, it can be seen that the toad venom extracts Fr.2 and Fr.3 obtained by the preparation method of the present application have significantly lower inflammatory properties than toad venom extracts Fr.1 and toad venom extracts Fr.4; and significantly lower pain properties than toad venom and toad venom extracts Fr.1. The toad venom extracts Fr.2 and Fr.3 obtained by the preparation method of the present application have lower irritation.

[0074] The above is an explanation of the embodiments of the present invention. However, the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for preparing a low-irritation toad venom extract, the method comprising the following steps: (1) Solvent extraction: Take toad venom, add alcohol solvent, extract, and filter to obtain the extract; (2) Gel chromatography purification: The extract is dissolved in methanol and centrifuged to obtain a supernatant sample; the supernatant sample is loaded onto a gel chromatography column, and after sufficient adsorption, the column is eluted with methanol and the fractions are collected; the fractions with a negative ninhydrin colorimetric reaction and a maximum ultraviolet absorption wavelength of 290 nm to 305 nm are collected to obtain the low-irritation toad venom extract.

2. The preparation method according to claim 1, characterized in that: In step (1), the alcohol solvent is selected from ethanol, methanol, etc.; Preferably, in step (1), during extraction, the concentration of the alcohol solvent is 70%-90%; Preferably, in step (1), the extraction method is selected from immersion extraction, ultrasonic extraction, reflux extraction, etc.; Preferably, in step (1), the extraction time is 10 h to 50 h, for example 12 h, 18 h, 24 h, 30 h, 36 h; Preferably, in step (1), the extraction times are 1-5 times.

3. The preparation method according to claim 1 or 2, characterized in that: In step (2), the extract is dissolved in methanol to a methanol concentration of 60% to 80%; Preferably, in step (2), the centrifugation parameters are: rotation speed 6000 rpm-10000 rpm, time 5 min-40 min.

4. The preparation method according to any one of claims 1 to 3, characterized in that In step (2), the gel chromatography column is a Sephadex LH-20 gel column; Preferably, in step (2), the loading step is specifically: aspirating the supernatant sample, adding it evenly and slowly along the glass inner wall of the gel chromatography column to fully adsorb; Preferably, in step (2), the elution solvent of the gel chromatography column is 60%-80% methanol.

5. The preparation method according to any one of claims 1 to 4, characterized in that: In step (2), the ultraviolet maximum absorption wavelength of the collected fraction is 295nm-302nm.

6. The preparation method according to any one of claims 1 to 5, characterized in that: In step (2), during the elution of the gel chromatography column, one tube was collected every 30 minutes, and a total of 165 tubes were collected; Preferably, in step (2), the color development reaction of ninhydrin of fractions 1-18 is positive, and the ultraviolet maximum absorption wavelength is 220 nm; the color development reaction of ninhydrin of fractions 20-29 is negative, and the ultraviolet maximum absorption wavelength is 296 nm; the color development reaction of ninhydrin of fractions 30-41 is negative, and the ultraviolet maximum absorption wavelength is 296 nm; the color development reaction of ninhydrin of fractions 42-165 is negative, and the ultraviolet maximum absorption wavelength is 276 nm.

7. The preparation method according to claim 6, characterized in that: In step (2), the 20th to 41st fractions are combined to obtain the low-irritation toad venom extract; Alternatively, in step (2), the 20th to 29th fractions are combined to obtain the low-irritation toad venom extract. Alternatively, in step (2), the 30th to 41st fractions are combined to obtain the low-irritation toad venom extract.

8. The preparation method according to any one of claims 1 to 7, characterized in that: The low-irritation toad venom extract is rich in steroidal components such as toad venom, toad venom, toad venom, and cinobuccal venom.

9. The low-irritation toad venom extract prepared by the preparation method according to any one of claims 1 to 8.